Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Microfluidics Files for Patent on Microfluidics Reaction Technology (MRT)

Abstract:
Microfluidics has filed for a patent on its Microfluidics Reaction Technology (MRT), which will enable companies and research organizations to develop and manufacture smaller-sized nanoparticles than previously possible and to do so more efficiently than with other methods. MRT was presented at the Nano Science and Technology Institute (NSTI) Nanotech 2007 and 2008 conferences and won a Nano 50™ award in 2007 as one of the most innovative ideas that will revolutionize nanotechnology in the near-term and beyond.

Microfluidics Files for Patent on Microfluidics Reaction Technology (MRT)

Newton, MA | Posted on January 16th, 2009

The patent covers processors, processes, and applications that are used to produce nanoparticles at high volume, high purity, and low cost. MRT can also be used for synthesis of fine chemicals through single or multiphase chemical reactions or physical processes such as crystallization. Another key use is process intensification, or combining chemical processes in ways that increase manufacturing efficiency, reduce energy use, and result in purer products.

MRT has a wide range of applications, including production of pharmaceutical nanosuspensions and of nanomaterials that are used for fuel cells and photovoltaics. It is particularly applicable for those pharmaceutical applications where the trend is to go to very small particles that have precise polymorph control. Microfluidics has demonstrated MRT by creating nanosuspensions of a variety of injectable or inhalable drugs, including cancer therapies, antibiotics, antihistamines, and non-steroidal anti-inflammatories, among others. "We used solvent/anti-solvent crystallization, precipitation, or chemical reactions to create these nanosuspensions," says Dr. Thomai "Mimi" Panagiotou, Microfluidics' Chief Technology Officer. "We were also able to encapsulate drugs in polymers using the same technique."

At the core of MRT is a continuous impinging jet microreactor (reaction chamber) with flow rates in liters or tens of liters per minute, capable of mixing the reactants at the nanometer level. The flow velocities inside the reaction chamber are orders of magnitude higher than that of existing impinging jet designs. Particles are built up molecule by molecule in fractions of a second. The process results in extreme purity of products and creates smaller particles than those ever before achieved.

Dr. Panagiotou noted "Most technologies that produce nanomaterials rely on ‘top down' approaches, i.e. breaking large particles into smaller particles. MRT creates nanoparticles from the ‘bottom up.' This is a more efficient approach and it can create smaller particles than ‘top down' methods. Crystals can be made to a targeted size range with no need for additional micronization, instead of making them and then breaking them down to the desired size."

####

About Microfluidics
Microfluidics, a wholly owned subsidiary of Microfluidics International Corporation, is a supplier of advanced fluid-processing equipment and reaction technology for laboratory, pilot-scale, and manufacturing applications. The equipment enables the manufacture and formulation of numerous nanomaterials and nanoscale products, and produces the most uniform and smallest liquid and suspended solid particles available.

Microfluidics has been a worldwide supplier of Microfluidizer® high-shear fluid- processing systems to the biotechnology, pharmaceutical, chemical and cosmetics industries since 1984. As a leader in the field, Microfluidics has enabled numerous companies and institutions to formulate, validate, and produce licensed drugs for the worldwide healthcare market.

Companies seeking to produce difficult-to-formulate products or to find better methods of bioprocessing can take advantage of complimentary sample testing at any of three Microfluidics facilities. Visit www.microfluidicscorp.com, email or contact Microfluidics at 800.370.5452 for application information.

For more information, please click here

Contacts:
Katie DePorter
Gray & Rice Public Relations
617.367.0100 ext. 121

Copyright © Microfluidics International Corporation

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Metal oxide sandwiches: New option to manipulate properties of interfaces February 8th, 2016

Canadian physicists discover new properties of superconductivity February 8th, 2016

Leading bugs to the death chamber: A kinder face of cholesterol February 8th, 2016

From allergens to anodes: Pollen derived battery electrodes February 8th, 2016

Microfluidics/Nanofluidics

Scientists have shown how to make a low-cost yet high precision glass nanoengraving: In a joint study, scientists have developed a mechanism of laser deposition of patterns on glass with a resolution of 1000 times lower than the width of a human hair January 21st, 2016

Nanoworld 'snow blowers' carve straight channels in semiconductor surfaces: NIST, IBM researchers report important addition to toolkit of 'self-assembly' methods eyed for making useful devices December 28th, 2015

New device uses carbon nanotubes to snag molecules: Nanotube “forest” in a microfluidic channel may help detect rare proteins and viruses December 21st, 2015

A cheap, disposable device for diagnosing disease December 2nd, 2015

Announcements

Scientists create laser-activated superconductor February 8th, 2016

Canadian physicists discover new properties of superconductivity February 8th, 2016

Leading bugs to the death chamber: A kinder face of cholesterol February 8th, 2016

From allergens to anodes: Pollen derived battery electrodes February 8th, 2016

Patents/IP/Tech Transfer/Licensing

Joint Efforts by Iranian, Malaysian Scientists Produce Antibacterial Coatings for Isolated Areas February 4th, 2016

Silicon-based metamaterials could bring photonic circuits February 1st, 2016

Therapeutic Solutions International Licenses Dexosome Clinical Stage Cancer Immunotherapy Product From Gustave Roussy European Cancer Centre: FDA Cleared Immuno-Oncology Technology to Resume Clinical Development for Solid Tumor Patients January 27th, 2016

Light-activated nanoparticles prove effective against antibiotic-resistant 'superbugs' January 19th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic